The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Antimicrobial Susceptibility Testing Market Projected To Reach By 2030?
The antimicrobial susceptibility testing market size has demonstrated significant expansion in recent years. It is anticipated to increase from $4.65 billion in 2025 to $4.93 billion in 2026, at a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to several factors, including the increasing occurrence of infectious diseases, heightened awareness of antimicrobial resistance, the expansion of clinical microbiology laboratories, increased volumes of hospital diagnostic testing, and the availability of standardized AST protocols.
The antimicrobial susceptibility testing market is projected to experience robust expansion in the coming years, with its size anticipated to reach $6.01 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.1%. This growth during the forecast period can be attributed to increasing investments in rapid diagnostic technologies, a rising adoption of AI-assisted laboratory analysis, the expansion of surveillance programs for antimicrobial resistance, a growing demand for point-of-care AST solutions, and an increasing focus on precision antimicrobial therapy. Major trends expected in the forecast period include a wider adoption of automated AST systems, an escalating demand for rapid diagnostic testing, the growing integration of molecular and phenotypic methods, the broadening of laboratory automation solutions, and an enhanced focus on antimicrobial resistance monitoring.
Access Your Free Sample Report For In-Depth Market Analysis:
What Major Factors Are Driving The Antimicrobial Susceptibility Testing Market Forward?
The global increase in the prevalence of infectious diseases has significantly contributed to the expansion of the antimicrobial susceptibility testing market. These diseases originate from organisms such as bacteria, viruses, fungi, and parasites. Among these, bacterial conditions include bacterial pneumonia and tuberculosis, alongside viral diseases like smallpox and AIDS, and others. For instance, data from March 2024, provided by the Centers for Disease Control and Prevention, a US-based national public health agency, highlighted that in 2023, among 9,573 TB cases where birth origin was identified, 7,259 (76%) affected non-U.S.–born persons. This marked an 18% rise compared to the 6,177 similar cases reported in 2022. Thus, the escalating incidence of infectious diseases is a primary driver for the growth of the antimicrobial susceptibility testing market.
How Is The Antimicrobial Susceptibility Testing Market Organized By Segment Classification?
The antimicrobial susceptibility testing market covered in this report is segmented –
1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types
2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables
3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications
4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)
Subsegments:
1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems
2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods
3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods
4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing
Which Trends Are Impacting The Progress Of The Antimicrobial Susceptibility Testing Market?
Leading companies active in the antimicrobial susceptibility testing market are developing innovative offerings, such as the First POC Testing System. This system detects the presence or absence of bacteria and assesses antimicrobial effectiveness using urine samples from patients believed to have urinary tract infections (UTIs). It represents a significant advancement in AST technologies, helping to accelerate the start of targeted antimicrobial therapy for individuals with infections. For example, in June 2023, Sysmex Corporation, a Japan-based company manufacturing reagents and equipment for clinical tests, including hematologic and immune assessments, launched a testing system for the rapid detection of antimicrobial susceptibility. Employing a unique and proprietary microfluidic technology, the system delivers antimicrobial susceptibility testing (AST) results in as little as 30 minutes from the start of measurement, which is a considerable reduction compared to the several days required for conventional AST.
Who Are The Industry Participants Involved In The Antimicrobial Susceptibility Testing Market?
Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S
Get The Full Antimicrobial Susceptibility Testing Market Report:
Which Region Is The Leading Market For The Antimicrobial Susceptibility Testing Market?
North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Antimicrobial Susceptibility Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Antimicrobial Susceptibility Testing Market 2026, By The Business Research Company
Infectious Disease Diagnostics Testing Market Report 2026
Veterinary Antimicrobial Susceptibility Testing Market Report 2026
Gastrointestinal Pathogen Testing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model